Related Experiment Videos
The radiation dose-rate effect in two human neuroblastoma cell lines
A Holmes1, T J McMillan, J H Peacock
1Radiotherapy Research Unit, Institute of Cancer Research, Sutton, Surrey, UK.
British Journal of Cancer
|November 1, 1990
Summary
Neuroblastoma cells (HX138 and HX142) show high sensitivity to radiation but also significant recovery. This radiobiology data is crucial for optimizing targeted radiotherapy treatments.
Area of Science:
- Radiobiology
- Oncology
- Radiation Therapy
Background:
- Targeted radiotherapy is used for neuroblastoma treatment.
- Understanding neuroblastoma radiobiology is essential for treatment optimization.
Purpose of the Study:
- Investigate the dose-rate effect on neuroblastoma cell lines (HX138 and HX142).
- Assess cellular recovery in split-dose experiments.
- Determine the radiobiological parameters for neuroblastoma cells.
Main Methods:
- Irradiation of HX138 and HX142 human neuroblastoma cell lines at various dose rates.
- Split-dose experiments to evaluate cellular recovery.
- Analysis using the linear-quadratic model to derive radiobiological parameters.
Main Results:
- Both cell lines demonstrated high sensitivity to high dose-rate irradiation.
- Significant sparing of radiation effects was observed at lower dose rates (below 2 cGy/min).
- Substantial cellular recovery was evident in split-dose experiments, with higher beta values than other human tumor cell lines.
Conclusions:
- Neuroblastoma cell lines HX138 and HX142 exhibit significant capacity for repairing radiation-induced DNA damage.
- Despite high sensitivity to ionizing radiation, substantial cellular recovery suggests potential for adaptive responses during radiotherapy.
- These findings are critical for refining radiotherapy strategies in neuroblastoma treatment.